Low Effectiveness of the Introduction of pmaxGFP into Primary Human Coronary Endothelial Cells Using Cell-Penetrating Peptides and Nuclear-Localization Sequences in Non-Covalent Interactions
Source abstract
Abstract
Cell-penetrating peptides (CPPs), due to their effectiveness and low cytotoxicity, are of increasing interest in the context of the transport of macromolecules to the cells. The simplest and safest method seems to be the non-covalent binding of CPP and cargo molecules. However, it requires the optimization of the reaction conditions. The study aimed to determine the effectiveness and cytotoxicity of the Pep-1, KALA, and TAT proteins as well as the NLS [47–55] and NLS [47–56] sequences derived from the Simian Vacuolating 40 (SV40) T-antigen in the context of the transport of the pmaxGFP plasmid to primary human coronary artery endothelial cells. The results are presented in the form of extensive photographic documentation, which shows significant differences in the efficiency of the transfection process between electroporation and the use of CPPs. The study presents negative results in which, despite the manipulation of various parameters (incubation time, incubation temperature, culture time, charge ratio, plasmid concentration), results similar to electroporation were not obtained.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Viral Infectious Diseases and Gene Expression in Insects
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-092 Bydgoszcz, Poland
Funding
National Science Centre, Poland
References (29)
Show source-provided references
1. Cell-penetrating peptides and their utility in genome function modifications (Review)
2. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides10.1016/j.addr.2007.03.004 ↗
3. CPP-mediated protein delivery in a noncovalent form: Proof-of-concept for percutaneous and intranasal delivery10.2174/0929866521666140807121903 ↗
4. Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form10.1016/j.ijpharm.2016.06.054 ↗
5. The Formation of Nanoparticles between Small Interfering RNA and Amphipathic Cell-Penetrating Peptides10.1016/j.omtn.2017.02.003 ↗
6. Liu, J., and Afshar, S. (2020). In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides. Int. J. Mol. Sci., 21.10.3390/ijms21134719 ↗
7. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation10.1038/82176 ↗
8. US National Library of Medicine (2021, January 12). ClinicalTrials.gov, Available online: https://clinicaltrials.gov/ct2/show/NCT00914914.
9. Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy10.18632/oncotarget.26442 ↗
10. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases10.1016/j.vph.2017.05.005 ↗
11. Widmer, R.J., Allison, T.G., Keane, B., Dallas, A., Bailey, K.R., Lerman, L.O., and Lerman, A. (2016). Workplace Digital Health Is Associated with Improved Cardiovascular Risk Factors in a Frequency-Dependent Fashion: A Large Prospective Observational Cohort Study. PLoS ONE, 11.10.1371/journal.pone.0152657 ↗
12. Endothelial dysfunction and systemic hypertension by selective cGMP-dependent protein kinase I inhibition using novel cell-penetrating peptide delivered in vivo10.1016/j.ijcard.2012.05.107 ↗
13. Expression and purification of PEP-1-EGFP fusion protein and its transduction into human umbilical vein endothelial cells
14. US National Library of Medicine (2021, January 12). ClinicalTrials.gov, Available online: https://www.clinicaltrials.gov/ct2/show/NCT00451256.
15. Cell-Penetrating Peptides: From Basic Research to Clinics10.1016/j.tips.2017.01.003 ↗
16. TAT-functionalized PEI-grafting rice bran polysaccharides for safe and efficient gene delivery10.1016/j.ijbiomac.2019.09.234 ↗
17. A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant10.1093/nar/gkv008 ↗
18. Relationships between Cargo, Cell Penetrating Peptides and Cell Type for Uptake of Non-Covalent Complexes into Live Cells10.3390/ph6020184 ↗
19. A non-covalent peptide-based strategy for protein and peptide nucleic acid transduction10.1016/j.bbamem.2006.02.006 ↗
20. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy10.1021/mp200481g ↗
21. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells10.1093/nar/25.14.2730 ↗
22. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells10.1074/jbc.M211891200 ↗
23. Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA10.1101/gr.171264.113 ↗
24. Nanosized, peptide-based multicomponent DNA delivery systems: Optimization of endosome escape activity10.2217/nnm.16.27 ↗
25. Peptide-Mediated Membrane Transport of Macromolecular Cargo Driven by Membrane Asymmetry10.1021/acs.analchem.7b03421 ↗
26. The uptake of HIV Tat peptide proceeds via two pathways which differ from macropinocytosis10.1016/j.bbamem.2014.12.015 ↗
27. PEP and CADY-mediated delivery of fluorescent peptides and proteins into living cells10.1016/j.bbamem.2010.02.027 ↗
28. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery10.1002/psc.2927 ↗
29. Cell membrane penetrating function of the nuclear localization sequence in human cytokine IL-1α10.1007/s11033-014-3711-7 ↗